• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠息肉癌中基质金属蛋白酶/基质金属蛋白酶组织抑制剂谱

The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers.

作者信息

Jeffery Natalie, McLean Mairi H, El-Omar Emad M, Murray Graeme I

机构信息

Department of Pathology, University of Aberdeen, Aberdeen, UK.

出版信息

Histopathology. 2009 Jun;54(7):820-8. doi: 10.1111/j.1365-2559.2009.03301.x.

DOI:10.1111/j.1365-2559.2009.03301.x
PMID:19635101
Abstract

AIMS

The matrix metalloproteinase (MMP)/tissue inhibitor of metalloproteinase (TIMP) system has a major role in tumour invasion and metastasis. Roles in pathways involved in early tumour development are also being identified for this system, and the aim of this study was to define the expression profile of the major MMPs and TIMPs in colorectal polyp cancers.

METHODS AND RESULTS

The expression and cellular localization of individual MMPs and TIMPs was determined in colorectal polyp cancers by immunohistochemistry. All the MMPs and TIMPs showed immunoreactivity in carcinomatous epithelium. MMP1 (P < 0.001), MMP2 (P = 0.003), MMP3 (P = 0.004), TIMP1 (P = 0.01) and TIMP2 (P < 0.001) showed significant increases in immunoreactivity in carcinomatous epithelium compared with adenomatous epithelium. MMP7 showed immunoreactivity in carcinomatous epithelium, but showed no immunoreactivity in either normal epithelium or adenomatous epithelium. MMP and TIMP expression was limited in normal epithelium to MMP1, MMP2 and TIMP3.

CONCLUSIONS

This study defines the expression profile of MMPs and TIMPs in colorectal polyp cancers and shows that the increased expression of MMPs and TIMPs occurs at an early stage of colorectal neoplasia. It provides evidence to support the hypothesis that these molecules have a key involvement in the early stages of tumour development.

摘要

目的

基质金属蛋白酶(MMP)/金属蛋白酶组织抑制剂(TIMP)系统在肿瘤侵袭和转移中起主要作用。该系统在肿瘤早期发展相关通路中的作用也正在被明确,本研究的目的是确定结直肠息肉癌中主要MMP和TIMP的表达谱。

方法与结果

通过免疫组织化学法测定结直肠息肉癌中各MMP和TIMP的表达及细胞定位。所有MMP和TIMP在癌上皮中均显示免疫反应性。与腺瘤上皮相比,MMP1(P < 0.001)、MMP2(P = 0.003)、MMP3(P = 0.004)、TIMP1(P = 0.01)和TIMP2(P < 0.001)在癌上皮中的免疫反应性显著增加。MMP7在癌上皮中显示免疫反应性,但在正常上皮或腺瘤上皮中均未显示免疫反应性。正常上皮中MMP和TIMP的表达仅限于MMP1、MMP2和TIMP3。

结论

本研究确定了结直肠息肉癌中MMP和TIMP的表达谱,并表明MMP和TIMP的表达增加发生在结直肠癌变的早期阶段。它为支持这些分子在肿瘤发展早期起关键作用这一假说提供了证据。

相似文献

1
The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers.结直肠息肉癌中基质金属蛋白酶/基质金属蛋白酶组织抑制剂谱
Histopathology. 2009 Jun;54(7):820-8. doi: 10.1111/j.1365-2559.2009.03301.x.
2
In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.金属蛋白酶MMP1、MMP2、MMP3、MMP9及其抑制剂TIMP1和TIMP2在人肾细胞癌中的原位基因表达及定位
Oncol Rep. 2006 May;15(5):1379-84.
3
Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers.基质金属蛋白酶/基质金属蛋白酶组织抑制剂表型可识别预后不良的结直肠癌。
Clin Cancer Res. 2004 Dec 15;10(24):8229-34. doi: 10.1158/1078-0432.CCR-04-0424.
4
Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma.基质金属蛋白酶家族表达在人类结直肠癌中的预后价值
J Surg Res. 2008 May 1;146(1):32-42. doi: 10.1016/j.jss.2007.02.011. Epub 2007 May 31.
5
Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal tumors and their synchronous liver metastases.原发性结直肠癌及其同步性肝转移灶中基质金属蛋白酶(MMPs)及其抑制剂(TIMPs)基因表达谱的差异。
Anticancer Res. 2009 Jan;29(1):67-74.
6
[Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal neoplasm].[基质金属蛋白酶及金属蛋白酶组织抑制剂在结直肠肿瘤中的表达]
Zhonghua Wai Ke Za Zhi. 2000 Jul;38(7):510-3.
7
Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.与周围非肿瘤组织相比,基质金属蛋白酶(MMPs)和金属蛋白酶组织抑制剂(TIMPs)在肝细胞癌组织中的表达情况。
Res Commun Mol Pathol Pharmacol. 2004;115-116:143-50.
8
Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma.基质金属蛋白酶2和9以及金属蛋白酶组织抑制剂1和2的表达增加与肾细胞癌的不良预后变量相关。
Clin Cancer Res. 2001 Oct;7(10):3113-9.
9
Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma.人类胰腺癌中基质金属蛋白酶(MMPs)与基质金属蛋白酶组织抑制剂(TIMPs)表达失衡
J Pathol. 1997 Jul;182(3):347-55. doi: 10.1002/(SICI)1096-9896(199707)182:3<347::AID-PATH848>3.0.CO;2-J.
10
Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.基质金属蛋白酶及其组织抑制剂在回肠类癌、淋巴结和肝转移灶中的表达与预后及生存的相关性
Neuroendocrinology. 2009;89(1):66-78. doi: 10.1159/000151482. Epub 2008 Aug 18.

引用本文的文献

1
The Role of Matrix Metalloproteinase-2 (MMP2) in Colorectal Cancer Progression: Correlation With Clinicopathological Features and Impact on Cellular Processes.基质金属蛋白酶-2(MMP2)在结直肠癌进展中的作用:与临床病理特征的相关性及对细胞过程的影响
Cureus. 2024 Jun 8;16(6):e61941. doi: 10.7759/cureus.61941. eCollection 2024 Jun.
2
Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures.新型小分子 LCC-21 通过抑制血管生成和转移特征抑制结直肠癌恶性的临床前评价。
Cells. 2023 Jan 9;12(2):266. doi: 10.3390/cells12020266.
3
Biogenic Selenium Nanoparticles and Their Anticancer Effects Pertaining to Probiotic Bacteria-A Review.
生物源硒纳米颗粒及其与益生菌相关的抗癌作用——综述
Antioxidants (Basel). 2022 Sep 27;11(10):1916. doi: 10.3390/antiox11101916.
4
Insights into the Role of Matrix Metalloproteinases in Precancerous Conditions and in Colorectal Cancer.基质金属蛋白酶在癌前病变和结直肠癌中的作用洞察
Cancers (Basel). 2021 Dec 10;13(24):6226. doi: 10.3390/cancers13246226.
5
Proteomic Analyses of Fibroblast- and Serum-Derived Exosomes Identify QSOX1 as a Marker for Non-invasive Detection of Colorectal Cancer.成纤维细胞和血清来源外泌体的蛋白质组学分析确定QSOX1为结直肠癌非侵入性检测的标志物。
Cancers (Basel). 2021 Mar 17;13(6):1351. doi: 10.3390/cancers13061351.
6
TIMP1 intron 3 retention is a marker of colon cancer progression controlled by hnRNPA1.TIMP1 内含子 3 保留是由 hnRNPA1 控制的结肠癌进展的标志物。
Mol Biol Rep. 2020 Apr;47(4):3031-3040. doi: 10.1007/s11033-020-05375-w. Epub 2020 Mar 21.
7
Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: A narrative review.结直肠源性腹膜癌病的分子荧光引导手术:一项叙述性综述。
J Surg Oncol. 2018 Aug;118(2):332-343. doi: 10.1002/jso.25106. Epub 2018 Jun 24.
8
Effect of subcutaneous treatment with human umbilical cord blood-derived multipotent stem cells on peripheral neuropathic pain in rats.人脐带血来源的多能干细胞皮下注射治疗对大鼠周围神经性疼痛的影响。
Korean J Physiol Pharmacol. 2017 Mar;21(2):153-160. doi: 10.4196/kjpp.2017.21.2.153. Epub 2017 Feb 21.
9
Expression of KAP1 in epithelial ovarian cancer and its correlation with drug-resistance.KAP1在上皮性卵巢癌中的表达及其与耐药性的相关性。
Int J Clin Exp Med. 2015 Oct 15;8(10):17308-20. eCollection 2015.
10
Relationship between single-nucleotide polymorphism of matrix metalloproteinase-2 gene and colorectal cancer and gastric cancer susceptibility: a meta-analysis.基质金属蛋白酶-2 基因单核苷酸多态性与结直肠癌和胃癌易感性的关系:荟萃分析。
Onco Targets Ther. 2015 Apr 16;8:861-9. doi: 10.2147/OTT.S78031. eCollection 2015.